JP2024533923A5 - - Google Patents
Info
- Publication number
- JP2024533923A5 JP2024533923A5 JP2023565316A JP2023565316A JP2024533923A5 JP 2024533923 A5 JP2024533923 A5 JP 2024533923A5 JP 2023565316 A JP2023565316 A JP 2023565316A JP 2023565316 A JP2023565316 A JP 2023565316A JP 2024533923 A5 JP2024533923 A5 JP 2024533923A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- povidone
- content
- surfactant
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111033229 | 2021-09-03 | ||
| CN202111033229.1 | 2021-09-03 | ||
| PCT/CN2022/116432 WO2023030430A1 (zh) | 2021-09-03 | 2022-09-01 | 一种滴眼给药预防和/或治疗白内障的眼用制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533923A JP2024533923A (ja) | 2024-09-18 |
| JP2024533923A5 true JP2024533923A5 (https=) | 2025-08-28 |
Family
ID=85349262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565316A Pending JP2024533923A (ja) | 2021-09-03 | 2022-09-01 | 点眼投与により白内障を予防および／または治療するための眼科用製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250000791A1 (https=) |
| EP (1) | EP4397302A4 (https=) |
| JP (1) | JP2024533923A (https=) |
| CN (1) | CN115737654B (https=) |
| WO (1) | WO2023030430A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008027340A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
| BRPI0909797A2 (pt) * | 2008-03-07 | 2017-08-22 | Sun Pharma Advanced Res Co Ltd | Composição oftálmica |
| CN102048725B (zh) * | 2009-10-29 | 2014-07-16 | 中国医学科学院药物研究所 | 紫杉醇胆固醇复合物 |
| US20170239273A1 (en) * | 2014-08-22 | 2017-08-24 | Kang Zhang | Compositions and methods to treat and/or prevent vision disorders of the lens of the eye |
| SG11201701377YA (en) | 2014-08-22 | 2017-03-30 | Kang Zhang | Compositions and methods to treat vision disorders |
| JP2018522070A (ja) * | 2015-07-27 | 2018-08-09 | キャタコア・インコーポレイテッドＣａｔａｃｏｒｅ， Ｉｎｃ． | 白内障の処置用組成物 |
| CN109481392B (zh) * | 2015-09-02 | 2021-12-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种用于预防和治疗白内障的眼用制剂及其制备方法 |
| CA2998134A1 (en) * | 2015-09-08 | 2017-03-16 | Viewpoint Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
| CN106344587A (zh) * | 2016-08-24 | 2017-01-25 | 上海毕傲图生物科技有限公司 | 羊毛甾醇类化合物眼用制剂 |
| CN107397745A (zh) * | 2016-08-24 | 2017-11-28 | 上海毕傲图生物科技有限公司 | 唑类化合物眼用制剂 |
| US20200281944A1 (en) * | 2017-11-17 | 2020-09-10 | Mahmood Piraee | Combinations Of Lanosterol Or 25-Hydroxycholesterol Including Derivatives Thereof Useful In The Treatment Of Lens Disorders |
| WO2020020306A1 (zh) * | 2018-07-25 | 2020-01-30 | 中山大学中山眼科中心 | 一种羊毛甾醇前药化合物的晶型及其应用 |
| CN110664757B (zh) * | 2018-11-19 | 2022-08-02 | 成都瑞沐生物医药科技有限公司 | 纳米晶滴眼剂、其制备方法及其应用 |
| WO2020177714A1 (zh) * | 2019-03-04 | 2020-09-10 | 中山大学中山眼科中心 | 一种羊毛甾醇前药化合物的组合物及其制备方法和应用 |
| US20200360403A1 (en) | 2019-05-16 | 2020-11-19 | Joseph Domenic SCIAMANNA | Opthalmic compositions for inhibiting clouding of the ocular lens |
-
2022
- 2022-08-23 CN CN202211014925.2A patent/CN115737654B/zh active Active
- 2022-09-01 EP EP22863565.2A patent/EP4397302A4/en active Pending
- 2022-09-01 JP JP2023565316A patent/JP2024533923A/ja active Pending
- 2022-09-01 WO PCT/CN2022/116432 patent/WO2023030430A1/zh not_active Ceased
- 2022-09-01 US US18/688,918 patent/US20250000791A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI415629B (zh) | 含有瑞巴匹特之水性醫藥懸浮物及其製造方法 | |
| WO2013025696A1 (en) | Ophthalmic formulations and processes for their preparation | |
| EP4424302A1 (en) | Ophthalmic preparation of tyrosine kinase inhibitor, and preparation method therefor and use thereof | |
| JP2025502601A5 (https=) | ||
| MX2007005782A (es) | Suspension oftalmica acuosa de rebamipida cristalina. | |
| WO2021032073A1 (en) | In-situ gel containing cyclosporine micelles as sustained ophthalmic drug delivery system | |
| MX2012004225A (es) | Formulacion oftalmica y metodo de fabricacion de la misma. | |
| JP2022062172A (ja) | 無菌眼用水性プロピオン酸フルチカゾンａ型ナノ結晶懸濁液の調製方法 | |
| CN113662915A (zh) | 一种眼用药物组合物 | |
| JP2024533923A5 (https=) | ||
| US12576126B2 (en) | Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof | |
| JP2808378B2 (ja) | 水性懸濁液剤の製造法 | |
| CN104721136A (zh) | 一种布佐林胺眼用纳米混悬剂及其制备方法 | |
| CN111939120A (zh) | 一种含二氟泼尼酯的原位凝胶眼用制剂 | |
| JPH02256618A (ja) | 懸濁型ピレノキシン点眼剤 | |
| EP2827838B1 (en) | Ophthalmic pharmaceutical composition containing a carbonic anhydrase inhibitor and method for the preparation thereof | |
| WO2004112789A1 (ja) | 眼科用組成物 | |
| CN112294761A (zh) | 一种难溶性药物的眼用胶束制剂 | |
| HK40077423A (en) | Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions | |
| HK40038382A (en) | Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions | |
| HK40038382B (en) | Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions |